(Press-News.org) Providing an overview of the submissions process and examples of U.S. Food and Drug Administration (FDA) applications for Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD), a new article can help developers of gene therapies for rare genetic diseases. The article is published in the peer-reviewed journal Human Gene Therapy. Click here to read the article now.
Anne Pariser and Elizabeth Ottinger, from the National Center for Advances in Translational Sciences (NCATS), National Institutes of Health, and coauthors, describe the ODD and RPDD programs, which provide financial incentives for the development of diagnostic drugs, preventive measures, and treatments of diseases affecting small patient populations.
To facilitate the standardization of gene therapy development of rare genetic diseases, the NCATS developed the Platform Vector Gene Therapy (PaVe-GT) program. The first adeno-associated virus gene therapy product for the treatment of PCCA-related propionic academia received ODD in 2021 and RPDD in 2022. In this article, members of the PaVe-GT program emphasize the significance of these incentive programs in stimulating drug development and illustrate how developers of gene therapies can utilize FDA guidance to prepare ODD or RPDD applications.
“The PaVe-GT program is pioneering regulatory and clinical trial approaches to broaden the impact of gene therapy,” says Editor-in-Chief Terence R. Flotte, MD, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Chan Medical School.
About the Journal
Human Gene Therapy, the Official Journal of the European Society of Gene and Cell Therapy and eight other international gene therapy societies, was the first peer-reviewed journal in the field and provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications. The Journal is led by Editor-in-Chief Terence R. Flotte, MD, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Chan Medical School, and an esteemed international editorial board. Human Gene Therapy is available in print and online. Complete tables of contents and a sample issue are available on the Human Gene Therapy website.
About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc. website.
END
Benefiting from orphan drug and rare pediatric disease designations for gene therapy
2023-03-27
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Study paves way to more efficient production of 2G ethanol using specially modified yeast strain
2023-03-27
A Brazilian study paves the way to increased efficiency of second-generation (2G) ethanol production based on the discovery of novel targets for metabolic engineering in a more robust strain of industrial yeast. An article on the study is published in the journal Scientific Reports.
The databases compiled by the authors are at the disposal of the scientific community in the repository of the State University of Campinas (UNICAMP), which is a member of the Dataverse Project, an international collaborative initiative supported by FAPESP.
First-generation (1G) ethanol is produced from sources rich in carbohydrates ...
UC Davis Health collaborates with Propeller Health to improve clinical outcomes of COPD patients
2023-03-27
UC Davis Health and Propeller Health have announced a new collaboration that will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease (COPD) aiming to improve their health outcomes.
As part of the collaboration, UC Davis Health will provide the Propeller program – including sensors, mobile app, web portal, and personalized support – to eligible patients, with eventual expansion to patients in other UC locations and UC affiliates. The sensors attach to a patient’s inhaler to capture unique signals that record events, such as ...
Largest study to date of minipuberty identifies two new patterns of the reproductive hormone, AMH, in infant girls
2023-03-27
Minipuberty is a stage of reproductive development during infancy in both sexes when reproductive hormones change and reproductive organs develop. The importance of minipuberty is not well understood but could represent an opportunity for the early identification of future reproductive conditions and enable prompt treatment. Anti-Müllerian hormone (AMH) is one of the hormones that changes during minipuberty, and it plays a key role in the development of reproductive organs in boys. However, the role of AMH in infant girls is less clear.
In ...
Bomb-sniffing rodents undergo ‘unusual’ reproductive transformations
2023-03-27
ITHACA, N.Y. – Female giant African pouched rats, used for sniffing out landmines and detecting tuberculosis, can undergo astounding reproductive organ transformations, according to a new study.
The paper, “Extreme plasticity of reproductive state in a female rodent,” which published March 27 in Current Biology, explores how traits once considered “fixed” in adult animals may become variable under specific pressures.
Though these rodents could have important military, biodetection and humanitarian uses, breeding them at high rates has been a challenge. ...
ENGOT-EN6-NSGO/GOG-3031/RUBY trial results: The new standard of care in advanced/recurrent endometrial cancer
2023-03-27
EMBARGO DATE: Monday, March 27, 2023, 12:30 pm ET
PRESS RELEASE
ENGOT-EN6-NSGO/GOG-3031/RUBY trial results:
The new standard of care in advanced/recurrent endometrial cancer
ENGOT, NSGO-CTU & GOG-Foundation proudly announce the ground-breaking results of ENGOT-EN6-NSGO/GOG-3031/RUBY trial.
The results reveal improvement in overall survival at 24 months in whole study population from 56% (CP+placebo) to 71.3% (CP+dostarlimab). “although these are interim data, we believe they are robust and will be confirmed with longer follow-up.”, said Mansoor R Mirza.
The trial is presented on 27th of March 2023 through ESMO’s ...
Human body a breeding ground for antimicrobial resistance genes
2023-03-27
The community of microbes living in and on our bodies may be acting as a reservoir for antibiotic resistance, according to new research from the Earlham Institute and Quadram Institute in Norwich.
The use of antibiotics leads to ‘collateral damage’ to the microbiome, ramping0 up the number of resistance genes being passed back and forth between strains in the microbiome.
The findings also suggest these genes spread so easily through a population that, regardless of your own health and habits, the number of resistance genes in your gut is heavily influenced by national trends in antibiotic consumption.
The rise of antimicrobial resistance (AMR) among human pathogens is widely seen ...
U of I study gives a thumbs up to carefully formulated vegan diets for dogs
2023-03-27
URBANA, Ill. – In today’s pet food market, there are products to match nearly every lifestyle, value system, and price point pet owners demand, including vegan formulations. New University of Illinois research shows at least two human-grade, lightly cooked vegan diets provide adequate nutrition for dogs.
“The trends of vegan foods and human grade foods are increasing for dogs. Because people are feeding these diets to their pets, it’s important they be tested like all other foods to make sure they're safe and ‘complete and balanced,’” ...
Epstein-Barr virus associated tumors and drug repurposing
2023-03-27
A new study published in the peer-reviewed OMICS: A Journal of Integrative Biology identified differentially expressed host and viral microRNAs (miRNAs) in six Epstein-Barr virus (EBV) associated tumors. The study reports several drug candidates for repurposing and targeting EBV latent infection: Glyburide, Levodopa, Nateglinide, and Stiripentol, among others. Click here to read the article now.
The authors, Anamika Thakur and Manoj Kumar, PhD, from the Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Chandigarh, India, note: “This is the first integrative analysis, to the best of our knowledge, in regard to the potential ...
Researchers identify 6 challenges humans face with artificial intelligence
2023-03-27
ORLANDO, March 27, 2023 - A University of Central Florida professor and 26 other researchers have published a study identifying the challenges humans must overcome to ensure that artificial intelligence is reliable, safe, trustworthy and compatible with human values.
The study, “Six Human-Centered Artificial Intelligence Grand Challenges,” was published in the International Journal of Human-Computer Interaction.
Ozlem Garibay ’01MS ’08PhD, an assistant professor in UCF’s Department ...
Mea6 deficiency in oligodendrocytes affects white matter formation in the brain
2023-03-27
More than half amount in adult human brain is made up of white matter. Lipid-rich myelin is a special structure formed by oligodendrocytes wrapping neuronal axons to form the major components of white matter. Abnormal myelin sheath is associated with many neurological diseases. Mea6/ cTAGE5C is essential for vesicle trafficking from ER to Golgi. However, its biological function in oligodendrocyte and white matter development remains unclear.
Scientists from Institute of Genetics and Developmental Biology of Chinese Academy of Sciences generated mice with conditional knockout (cKO) of Mea6 in oligodendrocytes. Using ...